Mittleider Derek, Green Linda C, Mann Victoria H, Michael Scott F, Didier Elizabeth S, Brindley Paul J
Department of Tropical Medicine, School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, USA.
J Eukaryot Microbiol. 2002 Sep-Oct;49(5):393-401. doi: 10.1111/j.1550-7408.2002.tb00218.x.
The microsporidian Vittaforma corneae has been reported as a pathogen of the human stratum corneum, where it can cause keratitis, and is associated with systemic infections. In addition to this direct role as an infectious, etiologic agent of human disease, V. corneae has been used as a model organism for another microsporidian, Enterocytozoon bieneusi, a frequent and problematic pathogen of HIV-infected patients that, unlike V. corneae, is difficult to maintain and to study in vitro. Unfortunately, few molecular sequences are available for V. corneae. In this study, seventy-four genome survey sequences (GSS) were obtained from genomic DNA of spores of laboratory-cultured V. corneae. Approximately, 41 discontinuous kilobases of V. corneae were cloned and sequenced to generate these GSS. Putative identities were assigned to 44 of the V. corneae GSS based on BLASTX searches, representing 21 discrete proteins. Of these 21 deduced V. corneae proteins, only two had been reported previously from other microsporidia (until the recent report of the Encephalitozoon cuniculi genome). Two of the V. corneae proteins were of particular interest, reverse transcriptase and topoisomerase IV (parC). Since the existence of transposable elements in microsporidia is controversial, the presence of reverse transcriptase in V. corneae will contribute to resolution of this debate. The presence of topoisomerase IV was remarkable because this enzyme previously had been identified only from prokaryotes. The 74 GSS included 26.7 kilobases of unique sequences from which two statistics were generated: GC content and codon usage. The GC content of the unique GSS was 42%, lower than that of another microsporidian, E. cuniculi (48% for protein-encoding regions), and substantially higher than that predicted for a third microsporidian, Spraguea lophii (28%). A comparison using the Pearson correlation coefficient showed that codon usage in V. corneae was similar to that in the yeasts, Saccharomyces cerevisiae (r = 0.79) and Shizosaccharomyces pombe (r = 0.70), but was markedly dissimilar to E. cuniculi (r = 0.19).
微孢子虫角膜小孢子虫已被报道为人类角质层的病原体,可引起角膜炎,并与全身感染有关。除了作为人类疾病的感染性病原体这一直接作用外,角膜小孢子虫还被用作另一种微孢子虫——比氏肠微孢子虫的模式生物,比氏肠微孢子虫是HIV感染患者中常见且棘手的病原体,与角膜小孢子虫不同,它很难在体外维持和研究。不幸的是,角膜小孢子虫的分子序列很少。在本研究中,从实验室培养的角膜小孢子虫孢子的基因组DNA中获得了74个基因组调查序列(GSS)。为了生成这些GSS,大约克隆并测序了41个不连续的千碱基角膜小孢子虫序列。基于BLASTX搜索,为44个角膜小孢子虫GSS指定了假定的身份,代表21种离散蛋白质。在这21种推导的角膜小孢子虫蛋白质中,只有两种先前在其他微孢子虫中被报道过(直到最近兔脑炎微孢子虫基因组的报道)。角膜小孢子虫的两种蛋白质特别令人感兴趣,即逆转录酶和拓扑异构酶IV(parC)。由于微孢子虫中转座元件的存在存在争议,角膜小孢子虫中逆转录酶的存在将有助于解决这一争论。拓扑异构酶IV的存在很显著,因为这种酶以前只在原核生物中被鉴定出来。这74个GSS包括26.7千碱基的独特序列,从中生成了两个统计数据:GC含量和密码子使用情况。独特GSS的GC含量为42%,低于另一种微孢子虫——兔脑炎微孢子虫(蛋白质编码区为48%),且远高于第三种微孢子虫——洛氏施普格孢虫预测的GC含量(28%)。使用皮尔逊相关系数进行的比较表明,角膜小孢子虫的密码子使用情况与酿酒酵母(r = 0.79)和粟酒裂殖酵母(r = 0.70)相似,但与兔脑炎微孢子虫明显不同(r = 0.19)。